application guidelines dengue tech challenge 2016 · dengue fever is a viral infectious disease...

18
APPLICATION GUIDELINES – DENGUE TECH CHALLENGE 2016 Supported by Powered by Funded through

Upload: others

Post on 08-Aug-2020

13 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

APPLICATION GUIDELINES –

DENGUE TECH CHALLENGE 2016

Supported by

Powered by

Funded through

Page 2: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

2

DENGUE TECH CHALLENGE 2016

Application Guidelines

Jointly powered by PlaTCOM Ventures and the British Council

Contents

1. INTRODUCTION......................................................................................................... 3

2. PROGRAMME FRAMEWORK ................................................................................. 5

3. AMOUNT PLEDGED ................................................................................................ 11

4. PROGRAMME TIMELINE ....................................................................................... 12

5. UK-MALAYSIA MATCHMAKING PLATFORM .................................................... 12

6. APPLICATION FORM AND SUBMISSION .......................................................... 12

7. FUND AGREEMENT ................................................................................................ 13

8. FUND DISBURSEMENT ......................................................................................... 14

9. PROJECT MONITORING AND EVALUATION ................................................... 15

10. SELECTION PROCESS .......................................................................................... 15

11. INTELLECTUAL PROPERTY RIGHTS (IPRs) ..................................................... 17

12. ETHICS AND RESEARCH GOVERNANCE ......................................................... 17

13. DATA PROTECTION ................................................................................................ 18

14. ENQUIRIES ................................................................................................................ 18

Page 3: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

3

1. INTRODUCTION

Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite

concerted dengue control programs, dengue fever remains a major public health

challenge in Malaysia. According to the World Health Organisation (WHO), as of 20

June 2015, there were 53,823 cases of dengue with 158 deaths reported in

Malaysia in 2015. This is 34% higher compared to the same reporting period in

2014. In one specific period, from 14 to 20 June 2015, there were 2,348 cases of

dengue reported, which was 8.6% higher than the number of cases reported in the

previous week. Despite continuing efforts in fighting this disease, prevention and

control efforts face many challenges and, to date, the approaches have largely been

reactive.

This initiative aims to support proposals for collaborative projects that bring together

experts from Malaysia and the United Kingdom to focus on commercialisation of

dengue-related research and products in Malaysia.

This initiative aims to:

support commercialisation of dengue research between organisations in

Malaysia and the United Kingdom

provide proactive solutions to dengue outbreaks in Malaysia

provide a platform for industry-academia commercialisation collaboration

activities in Malaysia and the United Kingdom

Proposals may focus, but are not limited to, the following areas:

1. Prevention – Vector Control, Vaccination

2. Diagnostic – Test kit

3. Patient Management – Medication, System

4. Others

About Newton-Ungku Omar Fund

The Newton Fund is a £375 million fund which, through science and innovation

partnerships, promotes the economic development and welfare of poor people in

partnering countries. It is part of the UK’s Official Development Assistance (ODA)

and aims to strengthen science and innovation capacity and unlock further funding

to support poverty alleviation. It is delivered through 15 UK delivery partners in

collaboration with 15 partner countries. Activities are in three broad areas:

People: increasing capacity for science and innovation in partner countries.

Research: research collaborations on development topics.

Translation: creating collaborative solutions to development challenges and strengthening innovation systems.

Page 4: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

4

For more information visit: www.newtonfund.ac.uk and follow via Twitter:

@NewtonFund

About the British Council

The British Council is the UK’s international organisation for cultural relations and

educational opportunities. We are on the ground in six continents and over 100

countries, bringing international opportunity to life, every day. Our work in Science

and Research links scientists globally and provides information for international

researchers on jobs and funding in the UK. Equally, we encourage grass-roots

discussion of science and sustainability issues.

About HIP2

High Impact Programme 2 addresses innovation gaps through a holistic and

'market-driven' approach, supporting innovation and industrial competitiveness. It

is designed to remove market and financing barriers to innovation. The major

benefits of this innovative commercialisation model will be reducing the risks

involved for SMEs to develop products and services with lower costs and faster

time-to-market, leveraging trusted technologies from across Malaysia and overseas

and receiving technology transfer and commercialisation support to further develop

innovation.

About PlaTCOM Ventures

PlaTCOM Ventures Sdn Bhd is the national technology commercialisation platform

of Malaysia. It is a wholly-owned subsidiary company of Agensi Inovasi Malaysia

(AIM) formed in collaboration with SME Corporation Malaysia under one of its six

High Impact Programmes (HIPs) in the SME Master Plan 2012-2020. PlaTCOM

Ventures is designed to discover and support innovations wherever they may be,

assess ideas very critically, explore them systematically, and turn the best ones into

successful products and services. Rather than following traditional technology

transfer models, PlaTCOM Ventures has designed a model that facilitates any

segment of the entire commercialisation process (end-to-end facilitation) from idea

to products and services. The whole approach is market driven in supporting

industrial innovation and competitiveness. The model is more suited to the

innovation environment in the South East Asia region, providing commercialisation

support for fledgling businesses, innovators and entrepreneurs including those from

academia and public research institutes.

Page 5: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

5

2. PROGRAMME FRAMEWORK

UK funding will be via the Newton-Ungku Omar Fund, under the British Council and

Malaysian funding will be via the High Impact Programme 2 (HIP2)/Concept-to-

Commercialisation Gap Fund (CCGF) under PlaTCOM Ventures. All UK applicants

will be funded and facilitated by the British Council and all Malaysian applicants will

be funded and facilitated by PlaTCOM Ventures via the Lead applicant.

UK funding will be disbursed to principal applicants of UK winning teams. Malaysian

funding will be disbursed to principal applicants of Malaysian winning teams.

Project duration

Projects can commence from 1 June 2016 and run until 31 May 2018. The maximum duration is 24 months.

Eligibility

The minimum composition of a team is one Malaysian principal applicant AND one

UK principal applicant. Both of the Principal Applicants’ institutions/organisations

(the ‘Lead Organisations’) must have the capacity to administer the grant. There

can only be two Principal Applicants (one each from Malaysia and the UK, country-

specific eligibility criteria are listed below) but if it will add value to your Team, you

can invite Associate Partners, from either Malaysia or the UK, to join your team.

Inclusion of Associate Partners is optional and there is no limit to the number of

Associate Partners, but please note that the Principal Applicants are responsible

for the deliverables of the entire project. Associate Partners can participate and join

a team with various roles including IP provider/licensor, consultant, developmental

research partner, etc. PlaTCOM Ventures and the British Council will only be

working directly with Malaysian and UK Principal Applicants, respectively.

The proposed project must contain elements of technological innovation leading to

commercialisation of dengue innovative products, processes and services. There

is no restriction as to where the proposed project is in the commercialisation

process; however, it must be demonstrated that the innovation has stalled due to

lack of funding to cross a specific market barrier. The Principal and Associate

Applicants (team members) must be competent in undertaking the proposed

project. CVs of the project leader and each team member as well as any other

supporting documents must also be submitted along with the application form.

Page 6: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

6

Specific eligibility criteria for the UK Principal Applicant:

a. A not-for-profit higher education institution with the capacity to undertake high-

quality research;

b. A not-for-profit research organisation with the capacity to undertake high-quality

research1;

c. Principal Applicant must be Leading Researchers2 or Established Researchers2;

d. Maximum grant for total of all UK applicant(s) per winning team is GBP180,000.

Specific eligibility criteria for the Malaysian Principal Applicant:

a. Principal Applicant must be a Malaysian majority-owned (minimum of 51%

equity) Small and Medium Enterprise (SME) based on the definition3 by SME

Corp;

b. Principal Applicant must have a minimum paid-up capital in cash of RM 10,000.

Start-up companies are exempt from this stipulation but must provide justification

and supporting documents regarding their sustainability. ability to sustain;

c. None of the company directors or project team members have been convicted

of any fraudulent activities or the company been declared bankrupt, under

liquidation or placed under receivership;

d. Maximum grant for total of all Malaysian applicant(s) per winning team is

MYR1,200,000.

In order to support the translation of research and innovation into benefit, Principal

Applicants are encouraged to include Associated Partners in their proposals.

a. Other research or higher education establishments

b. Not-for-profit organisations (including non-governmental organisations (NGOs))

c. For-profit/commercial organisations, including small and medium enterprises

(SMEs)

d. Individuals (subject matter experts, technology owners, etc.)

UK for-profit organisations and not-for-profit organisations (other than not-for-profit

higher education institutions or research organisations) are not eligible to apply as

Principal Applicants. Furthermore, for-profit organisations and individuals are not

eligible to receive any grant funds except to cover travel-associated costs.

1 Please see the list here http://www.britishcouncil.org/sites/britishcouncil.uk2/files/institutional_links_-_eligible_uk_research_organisations_-_version_1april_2015.pdf for a list of eligible UK research organisations. 2 For an indication of profiles for the two categories, we suggest applicants refer to the European Commission document ‘Towards a European framework for research careers’ http://ec.europa.eu/euraxess/pdf/research_policies/Towards_a_European_Framework_for_Research_Careers_final.pdf. 3 Please view this document for the latest definition: (http://www.smecorp.gov.my/vn2/sites/default/files/Guideline_for_New_SME_Definition_7Jan2014.pdf);

Page 7: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

7

Principal Applicants may submit more than one application provided that each

application is on a different dengue-related technology. However, assessment will

be conducted based on Principal Applicants and each Principal Applicant only

stands the chance of winning the Challenge through ONE application, the one

reviewed by our assessment panel as the best.

Scopes of funding covered:

COMPONENT OF FUNDING

The funding components consist of two sections. Section One (i to viii) is costs for Malaysian applicants and Section Two (ix to xii) is costs for UK applicants.

Section One: Costs for Malaysia only

i. Proof-of-concept (POC) and prototype development

ii. Productisation (industrial prototype development or redesigning the product as per regulatory requirements)

iii. Licensing support

iv. Testing & validation

v. Regulatory (certification)

vi. Technical assistance (Consultancy)

vii. Sector-specific market intelligence

viii. Incubation services (12–24 months)

Section Two: Costs for UK only

ix. Human resources cost

x. Other-research related costs (equipment, consumables, access to facilities/ library services, fieldwork)

xi. Operational costs (travel & subsistence, visa fees, medical insurance for visitors, meetings & events, interpreters & translation)

xii. Communication costs (publications, website, public engagement events)

Page 8: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

8

Costs for Malaysia only

i. Proof-of-Concept and Prototype Development

Proof-of-concept refers to the body of evidence (mostly a working prototype)

that needs to be produced in order to prove that the invention actually works.

For many inventions, proof-of-concept can take place at two occasions

along the commercialisation value chain. The first occurs at very early

stages from idea to proof-of-concept where a ‘research-grade’ prototype is

produced (mostly within the university or the research institute). The second

occasion is when the ‘research prototype’ needs to be redesigned to an

‘industry prototype’ that can actually be scaled up and sold in the market.

The fund will address both stages but under different categories. The

‘research prototype’ will be funded under the ‘Proof-of-Concept and

Prototype Development’ category and the ‘industry prototype’ under the

‘Productisation’ category as described below.

ii. Productisation

Productisation refers to the process of taking the ‘research prototype’ and

designing in all the details to ease manufacturability and lower costs, and

can also include any changes to make the product more sellable or

appealing to the market. Thus the ‘research prototype’ is transformed into

an ‘industry prototype’ that may or may not be refined further down the

commercialisation value chain through testing and validation, regulatory

certification and customer feedback once the product hits the market.

iii. Licensing Support (in-licensing)

In-licensing is the mechanism by which SMEs acquire Intellectual Property

Rights (IPRs) from external research organisations such as universities and

public research institutes as well as other entities (such as other SMEs, large

companies and MNCs). The acquired rights for the IPRs are used for

developing new products or improving existing products that confer the

licensee SME to gain a competitive advantage.

iv. Testing and Validation

Testing and validation is the process of ensuring that a design meets

requirements. Testing (also called ‘verification’) confirms that products

properly reflect the requirements specified for ensuring that ‘you built it

right’. Validation confirms that the product, as provided, will fulfil its intended

use, ensuring that ‘you built the right thing’. The risk of unexpected

bottlenecks can be reduced if testing and validation services can be

identified and accessed early on during the product development process.

Page 9: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

9

v. Regulatory (Certification)

Compliance with state, local and federal regulations is critical in obtaining

certification for marketing and distribution of new products and services.

Most products fail in the Malaysian market due to the lack of awareness of

regulatory certification bodies and the process by which certification can be

obtained.

vi. Technical Assistance (Consultancy)

SMEs in-licensing IPRs may need technical assistance from elsewhere to

integrate the in-licensed IPRs into their new or existing products under

development. This can be sourced from universities, external consultants

(local or overseas) and other experts. The usual route by which technical

assistance is obtained is via consultancy.

vii. Sector-Specific Market Intelligence

Provision of access to specialised sector-specific market data and market

information services including market intelligence reports, business models,

and specialised training in order to help the SME to strategise their business

model and thereby maximise the chances of commercial success through

thorough planning. Such intelligence enables the companies to make

informed decisions as well as to identify any unexpected market challenges.

viii. Incubation Services (Only applicable for Malaysian Principal applicant)

Business incubation provides SMEs and start-ups with the ideal location to

develop and grow their businesses, offering everything from virtual support,

rent-a-desk through to state of the art laboratories and everything in

between. This fund can be used to pay the fees and expenses required

under incubation services throughout the project duration.

Costs for UK only

ix. Human resources costs

Human resources costs that are essential, appropriate and relevant to the

collaboration (including costs of national insurance, pensions etc.), including

but not limited to:

Temporary research personnel dedicated to the project (full- or part-

time)

Research assistant salaries or fees

Research and data collection staff in the partner country

Page 10: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

10

x. Other-Research Related Costs

Essential research equipment4. The purchase cost of individual pieces

of equipment should be below £5,000. Purchase of equipment with an

initial cost of £5,000 or above must be agreed in advance with the

British Council.

Consumables5 (including scientific software licences dedicated to the

collaboration)

Access fees to facilities or library services.

xi. Operational Costs

Travel & subsistence, Visa fees, medical insurance for visitors,

Meetings & events, Interpreters & Translation

Costs of meetings, training events, seminars and conferences integral

to the collaboration (e.g. short-term room hire, projector, flip charts)

Basic catering costs associated with events or meetings directly

relating to the collaboration

Travel (economy class) and subsistence costs in line with British

Council policies

Visa fees, vaccinations, medical insurance for travel essential to the

collaboration, to the partner country

Bank charges for transfer of funds from the Lead Institution to

Associated Partners to cover their costs (only travel and expenses in

the case of for-profit organisations).

xii. Communication Costs

Publications, Website, Public Engagement events, Interpreters &

Translation

Publication costs and associated publishing and communications

costs (including web page development by external providers, if

appropriate) directly related to the collaboration; we particularly

encourage open access publishing

Note for UK applicants

To ensure value for money, the budget requested in your proposal (including

human resource costs) should cover only costs that are essential, appropriate

and relevant to the collaboration. The proposal should maximise cost share

through direct and indirect institutional contributions, other funding sources, and

4 Budget requests pertaining to these costs have to include any VAT costs, delivery and installation. 5 https://www.innovateuk.org/-/catapult-centres

Page 11: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

11

private sector support. Please indicate in the budget spreadsheet (and

application form):

Funds which the participating institutions will contribute from their own

funds (itemised as ‘in-kind contribution’), including staff time

Funds applied for from other sources to cover the collaboration; please

clarify the status of the funding applications (i.e. successful; decision

pending). Please indicate when you will know the outcome of any

pending applications.

There is no minimum requirement for in-kind funding in the application, but these

contributions will be looked upon favourably as a demonstration of long-lasting

commitment to the programme.

The grants cannot cover:

Staff time or replacement costs for permanent members of staff. It is

expected that these costs are covered by participating

institutions/organisations as an in-kind contribution.

Tuition fees

Bench fees

Costs relating to the construction, procurement or rental of physical

infrastructure (e.g. office buildings, laboratory facilities). It is expected

that any rooms and facilities essential for the routine operation of

collaboration are provided as an in-kind contribution by the participating

institutions, and these can be detailed as an in-kind contribution in the

budget breakdown.

Purchase or rental of office equipment (e.g. IT hardware, office software,

desks, chairs, filing cabinets, photocopiers, fax machines)

Patents or related costs (see Annex 1 for exceptions)

Costs related to writing up previous research

Mobile phone rental or purchase

Entertainment costs

Other indirect costs not listed above

3. AMOUNT PLEDGED

UK funding pledged by the British Council for this Challenge is GBP 500,000 and

Malaysian funding pledged by PlaTCOM Ventures is MYR 3,000,000.

Page 12: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

12

4. PROGRAMME TIMELINE

DATE ACTIVITIES

4 Jan 2016 Call for Applications goes live, interested Applicants register www.platcomdiscovery.com

1 Mar 2016

(6.00pm Malaysia, UTC +8:00)

Application submission closes

30 Apr 2016 Successful applicants informed

31 May 2016 Grant Agreement signed and grant disbursement conditional upon Collaboration Agreement signing

1 Jun 2016 – 31 May 2018 Project period

5. UK-MALAYSIA MATCHMAKING PLATFORM

From the time the Call for Applications goes live, interested Applicants need to

register on the web platform6 supported by PlaTCOM Ventures. Malaysian and

UK applicants need to identify fellow team members (UK or Malaysian counterparts,

respectively). To facilitate this, the web platform will allow uploading of profiles

which are accessible to all applicants who have registered. Applicants can send out

invitations to other applicants to join their team via this platform and from there they

are required to self-initiate the match-making process by engaging and contacting

the relevant applicants based on the field of technology, expertise,

commercialisation readiness, etc.

Upon successful self-initiated match-making, the Applicants form a Team and

determine the activities to be undertaken under the joint project by the respective

parties in order to deliver on commercialisable dengue solutions. Based on the

understanding established amongst all members of the Team, a joint Application

Form is completed and submitted by either the Malaysian or UK Principal applicant.

This will later be formalised in the form of a Collaboration Agreement to be signed

by all team members if the Application is successful.

6. APPLICATION FORM AND SUBMISSION

The Application Form is to be jointly completed by all Team members (i.e. all UK

and Malaysian applicants) and should clearly demonstrate the scope of the

6 www.platcomdiscovery.com

Page 13: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

13

activities to be undertaken under the project by the various team members. The

Form can be found on our web platform.

The completed Application Form is to be submitted by uploading it to the web

platform and clicking on “Submit Application”. The submission is only possible after

a Team (minimum composition of one Malaysian Principal Applicant and one UK

Principal Applicant) has been set up via the web platform. Only Principal Applicants

can submit the Form.

Along with the completed Application Form, both Malaysian and UK Principal

Applicants must submit the following documents:

DOCUMENT SUBMISSION

Malaysian/UK Principal Applicants

Duly signed copy of the completed Application Form

A detailed budget request using the budget spreadsheet provided

CVs of all project personnel involved in the execution of the project

Gantt Chart for proposed project timeline, activities, milestones and deliverables

Malaysian Principal Applicant only

Certified true copies of Form 9, Form 24, Form 44, and M&A of the Applicant company

Certified true copy of the Applicant company’s latest audited accounts / management accounts for the last three (3) years) (Malaysian lead applicant)

5-year Financial Projection (Income statement, balance sheet and cash flow)

Other attachments (e.g. supporting documents such as Letter of Intent, Letter of Interest, Technology/IP Licensing/Transfer Agreement, etc.)

UK Principal Applicant only

Supporting letter, on headed paper, signed by the Head of the institution or person with appropriate delegated authority, giving specific commitment to the project. Supporting letters are not to be signed by the Principal Applicants.

7. FUND AGREEMENT

Successful UK Applicants will sign a binding grant agreement between winning UK

Principal Applicants and the British Council. Winning Malaysian Principal Applicants

will sign a binding grant agreement with PlaTCOM Ventures.

Page 14: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

14

The Fund Agreements detail the terms and conditions of the funding, based on the

project proposed in the Application Form.

All Fund Agreements are to be signed by 31 May 2016 with the British Council and

PlaTCOM Ventures, respectively, and the following must be submitted by each

successful Team:

a. Collaborator Agreement amongst all team members defining among others, the

scope of work, roles, responsibilities and contribution of each team member, IP

sharing agreement amongst members – both background and foreground. (If a

template is required for reference, please inform PlaTCOM Ventures in advance

as this can be provided to all winning teams)

b. Technology Transfer/Licensing Agreement between the Technology Provider

and the Team or a particular Member, as agreed upon in the Collaboration

Agreement above (if relevant)

c. Consultancy Agreement between Consultant(s) and the Team or a particular

Member, as agreed upon in the Collaboration Agreement above (if relevant).

The Fund Agreements shall preclude any other arrangements by the team

members which are not declared in the Agreement. Throughout the duration of the

project, amendments may be made to the Agreement with the written consent of

the British Council, PlaTCOM Ventures and the team members.

8. FUND DISBURSEMENT

Fund disbursement for the winning UK Principal Applicants will be made in

stages by the British Council to the UK Lead Institutions. The amount awarded may

be less than the amount requested in the application. All budget requests are

assessed and amended if necessary to ensure the grant payment does not exceed

the maximum rates.

The British Council will pay 70% of the grant award within 30 days of receipt of the

signed Grant Agreement. Please note that the grant can only be paid to a bank

account belonging to your institution. The remaining 30% of the grant will be

processed pending the receipt and assessment of the Final Report.

Fund disbursement for the winning Malaysian Principal Applicants will be made

by PlaTCOM Ventures in stages according to the terms of the CCGF Agreement.

An initial payment will be disbursed upon execution of the project. The up-front initial

payment is strictly to be used to cover activities listed in the CCGF Agreement for

the achievement of the first milestone only. PlaTCOM Ventures has the absolute

Page 15: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

15

discretion to review the grant approval or the aggregate amount to be disbursed for

the project. Subsequent disbursements of the fund will be:

reimbursements of spent amounts,

based on the work completed in the project according to the pre-determined

milestones and deliverables, and

based on the completion of the due diligence by PlaTCOM Ventures.

9. PROJECT MONITORING AND EVALUATION

Project monitoring and evaluation of winning UK Principal Applicants will be

conducted by the British Council. Detailed instructions of the recipients’

responsibilities in fulfilling the project monitoring and reporting requirement will be

shared with successful applicants.

Project monitoring and evaluation of winning Malaysian Principal Applicants will be

conducted by PlaTCOM Ventures Project Management Team to ensure that all

criteria are adhered to accordingly.

The British Council and PlaTCOM Ventures reserve the right to suspend or

withdraw any commitment or support if there is non-compliance by any team

member. The Principal Applicants are required to submit all supporting documents

as specified in these Guidelines.

All parties in the Team must give full cooperation to achieve the set objectives,

milestones and deliverables as stipulated in the Collaborator Agreement,

regardless of the respective schedules of the Principal Applicants with PlaTCOM

Ventures and the British Council.

10. SELECTION PROCESS

Selection begins with an eligibility check against the eligibility criteria given in these

Guidelines.

Eligible proposals then undergo a quality review on the basis of:

Strength and quality of IP/innovation,

Market readiness,

Strength of project team and management,

Company structure (where relevant),

Sustainability and capacity building,

Unmet market need,

Likelihood of first sales upon completion,

Page 16: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

16

Lined-up customers engaged,

Relevance to economic development and social welfare,

Ease of market access,

Quantum of funding against project benefits (value for money),

In-kind resources,

Financial projection, etc.

The assessment process will be as follows:

Assessment and scoring by the UK and Malaysia experts. The Review

Panel considers whether proposals are of high quality (being intellectually

innovative, well-focused and methodologically sound), and whether the

activity has the potential to have a real impact on economic development

and social welfare in Malaysia

Review of development relevance against Official Development

Assistance7 (ODA) definitions established by the OECD and guidance

developed by the Newton Fund with advice from the UK Department for

International Development

7 For more on our approach to ODA, please see http://www.newtonfund.ac.uk/about/what-is-oda/

Applications received by 29 February 2016

STAGE 1

Eligibility Check by British Council and PlaTCOM separately

STAGE 2

Score Assessment by Panels

STAGE 3

Steering Committee assessment

Page 17: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

17

11. INTELLECTUAL PROPERTY RIGHTS (IPRs)

The IP generated under this project is encouraged to be protected by the suitable

IPR protection. The IP rights of the project shall be wholly owned by the team

members as stipulated in the Collaborator Agreement.

All Intellectual Property Rights shall remain the exclusive property of the owning

party. It is the responsibility of the Recipient, and all engaged in the research, to

agree between themselves in good faith negotiations regarding the ownership of

jointly developed intellectual property (IP) rights and to make every reasonable

effort to ensure that any new Intellectual Property Rights obtained in the course of

the research are used to the benefit of society and to address poverty.

All members will have to warrant in the Fund Agreements that the delivery of the

Project does not and will not infringe any third party’s Intellectual Property Rights

12. ETHICS AND RESEARCH GOVERNANCE

It is essential that all legal and professional codes of practice are followed in

conducting work supported by this Programme. Applicants must ensure the

proposed activity will be carried out to the highest standards of ethics and research

integrity. In the Application Form, they must clearly articulate how any potential

ethical and health and safety issues have been considered and how they will be

addressed (under the Project Risk section), ensuring that all necessary ethical

approval is in place before the project commences and all risks are minimised.

Specifically, applications that involve research on animals, human participants,

human tissue or patient/participant data must be accompanied by necessary

permission certificates from the relevant local ethical review committees/authorities

in Malaysia and the UK, or an effort to obtain this permission in advance of the

activity commencing. Failure to do this will result in applications being rendered

ineligible and any funding already committed through this Programme being

rescinded.

Please refer to the Research Councils UK ‘Policy and Guidelines on Governance

of Good Research Conduct’ (http://www.rcuk.ac.uk/Publications/researchers/grc/)

for further guidance.

Page 18: APPLICATION GUIDELINES DENGUE TECH CHALLENGE 2016 · Dengue fever is a viral infectious disease transmitted by mosquitoes. Despite concerted dengue control programs, dengue fever

18

13. DATA PROTECTION

As part of the application submission, the British Council and PlaTCOM Ventures

Sdn. Bhd. will ask applicants for permission to:

Use the information provided in the application for processing the

application and making any consequential award for the award payment,

monitoring, maintenance and review of the award. Information will be

shared with national Programme partners for the purpose of selection and

monitoring of the award.

Make information on the successful applications available to the public on

their website and other publicity, and in reports and documents.

Contact applicants in the future to inform them about future British Council

and PlaTCOM Ventures Sdn. Bhd. opportunities.

14. ENQUIRIES

All enquiries from the UK can be directed to:

British Council

Ground Floor, West Block, Wisma Selangor Dredging

142C Jalan Ampang 50450 Kuala Lumpur

T: +60 (0)3 2723 7929

E: [email protected]

All enquiries from Malaysia can be directed to:

PlaTCOM Ventures

3501, Level 3, Quill Building 3,

Jalan Teknokrat 5,

63000 Cyberjaya,

Selangor, Malaysia

T: 03-8319 3116

E: [email protected]